ROTIGOTINE | ROTIGOTINE | ATC N04BC09
NERVOUS SYSTEM NON-ERGOLINE DOPAMINE AGONISTS TREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON DISEASE AND RESTLESS LEGS SYNDROME | TRANSDERMAL | Cmax 3.8 NANOMOLAR VD 5460 LITER (65 KILOGRAM) PPB 92 PERCENT Cl 630 LITER / HOUR (EQN) HT 6 HOUR | DOPAMINE RECEPTOR | D2-LIKE DOPAMINE RECEPTOR AGONIST CHEMBL2331075 D2-LIKE DOPAMINE RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |